Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01375010 · ClinicalTrials.gov registry record · Phase 1
Vitamin D HIV Study on Postmenopausal Women
A Phase 1 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 1
- Development phase
- 85
- Enrollment target
NCT01375010 is a Phase 1 study that has completed, run by Columbia University. The registered enrollment target is 85 participants.
The verdict
NCT01375010, a Phase 1 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of vitamin D on measures of bone health and immune function in HIV infected postmenopausal women. The investigators prior research with this population revealed that low vitamin D levels are very common. Prior research with this population also revealed that Vitamin D is necessary for the body to absorb calcium and is important for the health of the bones. When vitamin D levels are low, there are increased risks of bone loss, muscle weakness, falls and fractures. Low levels of vitamin D have also been associated with impaired immune function. This study will help us learn whether two different doses of vitamin D will improve bone health and immune function.
Interventions
- OTHER Placebo
- DRUG Vitamin D3
- DRUG Vitamin Supplements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2011-01 |
| Est. Completion | 2016-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01375010
The ClinicalTrials.gov registry entry for NCT01375010 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01375010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01375010 about?
NCT01375010 is a clinical study titled "Vitamin D HIV Study on Postmenopausal Women". The purpose of this study is to determine the effects of vitamin D on measures of bone health and immune function in HIV infected postmenopausal women. The investigators prior research with this population revealed that low vitamin D levels are very common. Prior research with this population also r...
What is the current status of trial NCT01375010?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 85 participants. The study started on 2011-01. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01375010?
The interventions under investigation include: Placebo (OTHER), Vitamin D3 (DRUG), Vitamin Supplements (DRUG).
Who is sponsoring clinical trial NCT01375010?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.